MARIA TERESA ABREU

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. pmc In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer
    Daniel A Sussman
    Division of Gastroenterology, Department of Medicine, University of Miami, 1120 NW 14th Street, Clinical Research Building 310J, Miami, FL 33136, USA
    J Exp Clin Cancer Res 33:45. 2014
  2. pmc TLR4 activates the β-catenin pathway to cause intestinal neoplasia
    Rebeca Santaolalla
    Division of Gastroenterology, Department of Medicine, University of Miami, Leonard Miller School of Medicine, Miami, Florida, USA
    PLoS ONE 8:e63298. 2013
  3. pmc Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
    BMC Med Genet 12:63. 2011
  4. pmc The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia
    Yasmin Hernandez
    Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    BMC Gastroenterol 10:82. 2010
  5. ncbi request reprint Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study
    Maria T Abreu
    University of Miami Miller School of Medicine, Miami, FL 33101 6960, USA
    Inflamm Bowel Dis 15:829-36. 2009
  6. ncbi request reprint Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function
    Maria T Abreu
    Division of Gastroenterology, University of Miami Miller School of Medicine, P O Box 016960 D 49, Miami, Florida 33101, USA
    Nat Rev Immunol 10:131-44. 2010

Collaborators

  • William J Sandborn
  • Gert Van Assche
  • Emil Bisaccia
  • Christian Von Tirpitz
  • Thomas Ochsenkuhn
  • Stephen Hanauer
  • Daniel A Sussman
  • Rebeca Santaolalla
  • Pablo A Bejarano
  • John Sotolongo
  • Masayuki Fukata
  • Cristhine Pastorini
  • Inga Peter
  • Yasmin Hernandez
  • Monica T Garcia-Buitrago
  • Jennifer Clarke
  • Maria T Perez
  • Oname Burlingame
  • Ramanarao Dirisina
  • Jose R Ruiz
  • Sakhi Philip
  • Jeffrey Ko
  • Mansoor M Ahmed
  • Cecilia L España
  • Limin Shang
  • Sergio A Lira
  • Julie M Davies
  • Terrence A Barrett
  • Anthony Weiss
  • Jianzhong Hu
  • Robert J Desnick
  • Barry Jaffin
  • Keith Benkov
  • Burton I Korelitz
  • Joel Bauer
  • Laurie Ozelius
  • Peter Rubin
  • David Sachar
  • Monica Erazo
  • Dana Doheny
  • Simon Lichtiger
  • Adele A Mitchell
  • Thomas Ullman
  • Steven Itzkowitz
  • Lloyd Mayer
  • Arthur Kornbluth
  • Daniel H Present
  • James Aisenberg
  • Daisy Conduah
  • Keith Breglio
  • Lory A Hayes
  • Anli Chen
  • Ryan Ungaro
  • David Hsu
  • Ruliang Xu

Detail Information

Publications6

  1. pmc In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer
    Daniel A Sussman
    Division of Gastroenterology, Department of Medicine, University of Miami, 1120 NW 14th Street, Clinical Research Building 310J, Miami, FL 33136, USA
    J Exp Clin Cancer Res 33:45. 2014
    ..To explore the relationships between TLR4 expression and CRC, we combined the strength of transcriptome array data and immunohistochemical (IHC) staining...
  2. pmc TLR4 activates the β-catenin pathway to cause intestinal neoplasia
    Rebeca Santaolalla
    Division of Gastroenterology, Department of Medicine, University of Miami, Leonard Miller School of Medicine, Miami, Florida, USA
    PLoS ONE 8:e63298. 2013
    ..Our studies highlight a previously unexplored link between innate immune signaling and activation of oncogenic pathways, which may be targeted to prevent or treat CRC...
  3. pmc Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
    BMC Med Genet 12:63. 2011
    ..We evaluated a set of well-established CD-susceptibility variants to determine if they can explain the increased CD risk in the AJ population...
  4. pmc The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia
    Yasmin Hernandez
    Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    BMC Gastroenterol 10:82. 2010
    ....
  5. ncbi request reprint Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study
    Maria T Abreu
    University of Miami Miller School of Medicine, Miami, FL 33101 6960, USA
    Inflamm Bowel Dis 15:829-36. 2009
    ..A prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ECP in patients with active Crohn's disease (CD) who were refractory to or intolerant of immunosuppressants and/or anti-TNF therapies...
  6. ncbi request reprint Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function
    Maria T Abreu
    Division of Gastroenterology, University of Miami Miller School of Medicine, P O Box 016960 D 49, Miami, Florida 33101, USA
    Nat Rev Immunol 10:131-44. 2010
    ..Thus, dysregulated TLR signalling by intestinal epithelial cells may explain how colonic bacteria and inflammation promote colorectal cancer...